Insmed Email Format

Biotechnology Research
1,001-2,500 employees
Bridgewater Township, NJ, USA

Insmed is a global biopharmaceutical company dedicated to developing and delivering first- and best-in-class therapies for patients facing serious diseases.

Find contacts at Insmed

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@insmed.com

Company Overview

Industry
Biotechnology Research
Founded
1999
Headquarters
Bridgewater Township, NJ, USA
Revenue
$250M-$500M
FUNDING Stage
Public
Key Executives
William H. Lewis (Chair and Chief Executive Officer), Sara M. Bonstein (Chief Financial Officer), Roger Adsett (Chief Operating Officer)

Tech Stack

Snowflake

Analytics

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Insmed?

Insmed uses the first.last format, so Jane Smith would be jane.smith@insmed.com.

What approved products does Insmed currently sell?

Insmed has two approved commercial products: ARIKAYCE (amikacin liposome inhalation suspension) for refractory MAC lung disease and BRINSUPRI (brensocatib) for non-cystic fibrosis bronchiectasis, both targeting serious respiratory conditions.

Which geographic markets does Insmed operate in?

Insmed operates in the United States, Europe, and Japan, with ARIKAYCE generating international revenues and BRINSUPRI currently launched in the U.S. market. The company maintains offices and research locations across all three regions.

How many people work at Insmed?

Insmed employs approximately 1,670 people. If you need to reach a specific contact there, tools like Clay can help you find and verify the right person's email using the first.last@insmed.com format.

Beyond respiratory disease, what other therapeutic areas is Insmed pursuing in its pipeline?

Insmed is advancing programs in Immunology and Inflammation and Neuro and Other Rare diseases, alongside early-stage research in gene therapy, AI-driven protein engineering, and RNA end-joining technologies.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles